MSF Field Research > 1 Published Research and Commentary > Leishmaniasis/Kala Azar > Browsing MSF

Browsing "Leishmaniasis/Kala Azar" by Issue Date

Jump to a point in the index:
Or type in a year:

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 20 of 55
Issue DateTitleAuthor(s)
Feb-2014 Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?Salih, Niven A; van Griensven, Johan; Chappuis, François; Antierens, Annick; Mumina, Ann; Hammam, Omar; Boulle, Philippa; Alirol, Emilie; Alnour, Mubarak; Elhag, Mousab S; Manzi, Marcel; Kizito, Walter; Zachariah, Rony
Jan-2014 Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, IndiaBurza, Sakib; Sinha, Prabhat K; Mahajan, Raman; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Balsegaram, Manica; Das, Pradeep
Jan-2014 Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, IndiaBurza, Sakib; Sinha, Prabhat Kumar; Mahajan, Raman; Sanz, Marta González; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Das, Pradeep
Jan-2014 Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, IndiaBurza, Sakib; Sinha, Prabhat K; Mahajan, Raman; Lima, María Angeles; Mitra, Gaurab; Verma, Neena; Balasegarem, Manica; Das, Pradeep
11-Nov-2013 Clinical Epidemiology, Diagnosis and Treatment of Visceral Leishmaniasis in the Pokot Endemic Area of Uganda and KenyaMueller, Yolanda K; Kolaczinski, Jan H; Koech, Timothy; Lokwang, Peter; Riongoita, Mark; Velilla, Elena; Brooker, Simon J; Chappuis, François; Epicentre, Paris, France; Faculty of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom; Médecins Sans Frontières, Operational Centre, Geneva, Switzerland; Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Nov-2013 One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, IndiaBurza, Sakib; Nabi, Emara; Mahajan, Raman; Mitra, Gaurab; Lima, María Angeles
26-Sep-2013 Validation of Two Rapid Diagnostic Tests for Visceral Leishmaniasis in KenyaMbui, Jane; Wasunna, Monique; Balasegaram, Manica; Laussermayer, Adrian; Juma, Rashid; Njenga, Simon Njoroge; Kirigi, George; Riongoita, Mark; de la Tour, Roberto; van Peteghem, Joke; Omollo, Raymond; Chappuis, François
11-Dec-2012 Liposomal amphotericin B as a treatment for human leishmaniasisBalasegaram, Manica; Ritmeijer, Koert; Lima, Maria Angeles; Burza, Sakib; Ortiz Genovese, Gemma; Milani, Barbara; Gaspani, Sara; Potet, Julien; Chappuis, François; Drugs for Neglected Diseases Initiative, Geneva, Switzerland;2 Médecins Sans Frontières, Operational Centre Amsterdam, Amsterdam, The Netherlands; Médecins Sans Frontières, Operational Centre Barcelona Athens, Barcelona, Spain; Médecins Sans Frontières, Access Campaign, Paris, France; Médecins Sans Frontières, Operational Centre Geneva, Geneva, Switzerland;Médecins Sans Frontières, Access Campaign, Geneva, Switzerland; University of Geneva, andGeneva University Hospitals, Division of International and Humanitarian Medicine, 6, rue Gabrielle-Perret-Gentil, 1211 Geneva 14, Switzerland.
Nov-2012 Burden of visceral leishmaniasis in villages of eastern gedaref state, Sudan: an exhaustive cross-sectional survey.Mueller, Yolanda Kathrin; Nackers, Fabienne; Ahmed, Khalid A; Boelaert, Marleen; Djoumessi, Jean-Claude; Eltigani, Rahma; Gorashi, Himida Ali; Hammam, Omer; Ritmeijer, Koert; Salih, Niven; Worku, Dagemlidet; Etard, Jean-François; Chappuis, François; Epicentre, Paris, France; Médecins Sans Frontières - Operational Centre Geneva, Geneva, Switzerland; Institute of Tropical Medicine, Antwerp, Belgium; Federal Ministry of Health, Khartoum, Sudan;Community Medicine Department, University of Gedaref, Gedaref, Sudan; Médecins Sans Frontières - Operational Centre Amsterdam, Amsterdam, Holland; Institut de Recherche pour le Développement (IRD), Montpellier, France; Médecins Sans Frontières - Operational Centre Amsterdam, Amsterdam, Holland.
Jun-2012 Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled TrialMusa, Ahmed; Khalil, Eltahir; Hailu, Asrat; Olobo, Joseph; Balasegaram, Manica; Omollo, Raymond; Edwards, Tansy; Rashid, Juma; Mbui, Jane; Musa, Brima; Abuzaid, Abuzaid Abdalla; Ahmed, Osama; Fadlalla, Ahmed; El-Hassan, Ahmed; Mueller, Marius; Mucee, Geoffrey; Njoroge, Simon; Manduku, Veronica; Mutuma, Geoffrey; Apadet, Lilian; Lodenyo, Hudson; Mutea, Dedan; Kirigi, George; Yifru, Sisay; Mengistu, Getahun; Hurissa, Zewdu; Hailu, Workagegnehu; Weldegebreal, Teklu; Tafes, Hailemariam; Mekonnen, Yalemtsehay; Makonnen, Eyasu; Ndegwa, Serah; Sagaki, Patrick; Kimutai, Robert; Kesusu, Josephine; Owiti, Rhoda; Ellis, Sally; Wasunna, Monique; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan; Addis Ababa University, Addis Ababa, Ethiopia; Makerere University, Kampala, Uganda; Médecins Sans Frontières-Holland, Amsterdam, The Netherlands; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya; Faculty of Medicine, Gedaref University, Gedaref, Sudan; Gondar University, Gondar, Ethiopia; Arba Minch Hospital, Regional Health Bureau of SNNPR State, Arba Minch, Ethiopia; University of Nairobi, Nairobi, Kenya; Amudat Hospital, Amudat, Uganda
5-Mar-2012 Low castes have poor access to visceral leishmaniasis treatment in Bihar, IndiaPascual Martínez, F; Picado, A; Roddy, P; Palma, P; Médecins Sans Frontières - Operational Center Barcelona-Athens, Barcelona, Spain; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK
Oct-2011 Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, IndiaSinha, Prabhat K; van Griensven, Johan; Pandey, Krishna; Kumar, Nawin; Verma, Neena; Mahajan, Raman; Kumar, Pankaj; Kumar, Ranjeet; Das, Pradeeb; Mitra, Gaurab; Flevaud, Laurence; Ferreyra, Cecilia; Remartinez, Daniel; Pece, Manuel; Palma, Pedro Pablo; Rajendra Memorial Research Institute of Medical Science, Patna, Bihar; Medecins Sans Frontieres–India, Operational Center Barcelona–Athens, New Delhi, India; Institute of Tropical Medicine, Antwerp, Belgium; Medecins Sans Frontieres, Medical Department, Operational Center Barcelona– Athens, Barcelona, Spain
1-Apr-2011 Who Is a Typical Patient with Visceral Leishmaniasis? Characterizing the Demographic and Nutritional Profile of Patients in Brazil, East Africa, and South AsiaHarhay, Michael O; Olliaro, Piero L; Vaillant, Michel; Chappuis, François; Lima, María Angeles; Ritmeijer, Koert; Costa, Carlos Henrique; Costa, Dorcas Lamounier; Rijal, Suman; Sundar, Shyam; Balasegaram, Manica; Graduate Group in Demography, University of Pennsylvania, Philadelphia, Pennsylvania; United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland; Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom; Clinical Epidemiology and Public Health Unit, Center for Health Studies, Centre de Recherche Publique (CRP-Santé), Luxembourg; Médecins Sans Frontières, Operational Centre Geneva (MSF-OCG), Geneva, Switzerland; Division of International and Humanitarian Medicine, Geneva University Hospitals and University of Geneva, Geneva, Switzerland; Médecins Sans Frontières, Operational Centre Barcelona-Athens (MSF-OCBA), Barcelona, Spain; Médecins Sans Frontières, Operational Centre Amsterdam (MSF-OCA), Amsterdam, The Netherlands; Instituto de Doenças Tropicais Natan Portella, Teresina, Piauí, Brazil; Federal University of Piauí, Piauí, Brazil; Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Department of Internal Medicine, B. P. Koirala Institute of Health Sciences, Dharan, Nepal; Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
15-Nov-2010 High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin BChappuis, François; Alirol, Emilie; Worku, Dagemlidet T; Mueller, Yolanda; Ritmeijer, Koert; Médecins Sans Frontières, Geneva, Switzerland; Médecins Sans Frontières, Amsterdam, The Netherlands
26-Oct-2010 Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized TrialHailu, Asrat; Musa, Ahmed; Wasunna, Monique; Balasegaram, Manica; Yifru, Sisay; Mengistu, Getahun; Hurissa, Zewdu; Hailu, Workagegnehu; Weldegebreal, Teklu; Tesfaye, Samson; Makonnen, Eyasu; Khalil, Eltahir; Ahmed, Osama; Fadlalla, Ahmed; El-Hassan, Ahmed; Raheem, Muzamil; Mueller, Marius; Koummuki, Yousif; Rashid, Juma; Mbui, Jane; Mucee, Geoffrey; Njoroge, Simon; Manduku, Veronica; Musibi, Alice; Mutuma, Geoffrey; Kirui, Fredrick; Lodenyo, Hudson; Mutea, Dedan; Kirigi, George; Edwards, Tansy; Smith, Peter; Muthami, Lawrence; Royce, Catherine; Ellis, Sally; Alobo, Moses; Omollo, Raymond; Kesusu, Josephine; Owiti, Rhoda; Kinuthia, John; Addis Ababa University, Ethiopia; Institute of Endemic Diseases, University of Khartoum, Sudan; Centre for Clinical Research, Kenya Medical Research Institute, Kenya; Medecins Sans Frontieres, Amsterdam; Drugs for Neglected Diseases initiative (DNDi), Switzerland; Gondar University, Ethiopia; Arba Minch Hospital, Regional Health Bureau of SNNP state, Ethiopia; Faculty of Medicine, Gedaref University, Sudan; London School of Hygiene and Tropical Medicine, United Kingdom
Aug-2010 Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, IndiaPrabhat K. Sinha; Paul Roddy; Pedro Pablo Palma; Alice Kociejowski; María Angeles (Nines) Lima; Vidya Nand Rabi Das; Jitendra Gupta; Nawin Kumar; Gaurab Mitra; Jean-François Saint-Sauveur; Siju Seena; Manica Balasegaram; Fernando Parreño; Krishna Pandey; Medecins Sans Frontieres
8-Jun-2010 Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trendsGorski, Stanislaw; Collin, Simon M; Ritmeijer, Koert; Keus, Kees; Gatluak, Francis; Mueller, Marius; Davidson, Robert N; Médecins Sans Frontières, Amsterdam, The Netherlands; Department of Social Medicine, University of Bristol, Bristol, United Kingdom; Department of Infection and Tropical Medicine, Northwick Park Hospital, Harrow, United Kingdom
1-Sep-2009 Natural history of a visceral leishmaniasis outbreak in highland EthiopiaHerrero, Mercè; Orfanos, Giannos; Argaw, Daniel; Mulugeta, Abate; Aparicio, Pilar; Parreño, Fernando; Bernal, Oscar; Rubens, Daniel; Pedraza, Jaime; Lima, Maria Angeles; Flevaud, Laurence; Palma, Pedro Pablo; Bashaye, Seife; Alvar, Jorge; Bern, Caryn; Disease Prevention and Control Programmes, World Health Organization, Addis Ababa, Ethiopia; Médecins Sans Frontières-Ethiopia, Operational Centre Barcelona-Athens, Addis Zemen, Ethiopia; Department for the Control of Neglected Tropical Diseases, Leishmaniasis Control Program, World Health Organization, Geneva, Switzerland; National Centre of Tropical Medicine, Instituto de Salud Carlos III, Madrid, Spain; Médecins Sans Frontières, Medical Department, Operational Centre Barcelona-Athens (OCBA), Barcelona, Spain; Malaria and Other Vector Borne Diseases, Prevention and Control Program, Ministry of Health, Addis Ababa, Ethiopia; Division of Parasitic Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
1-Sep-2009 Developments in the treatment of visceral leishmaniasisden Boer, Margriet Leontine; Alvar, Jorge; Davidson, Robert N; Ritmeijer, Koert; Balasegaram, Manica; Medecins Sans Frontieres, Amsterdam, The Netherlands
Aug-2009 Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda.Mueller, Y; Mbulamberi, Dawson B; Odermatt, Peter; Hoffmann, Axel; Loutan, Louis; Chappuis, François; Médecins Sans Frontières, Geneva, Switzerland. yolanda.muller@geneva.msf.org
Showing results 1 to 20 of 55

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Apr 18, 2014